- All
- Product Management
- News
- Introduction
- Enterprise outlets
- FAQ
- Enterprise Video
- Enterprise Atlas
News | Multiple projects of Chuangyuan Biotech have been recognized as outstanding achievements in the 2023 Tianjin Quality Improvement Initiative.

On December 13, the Tianjin Municipal Market Supervision Administration announced the results of the 2023 Tianjin Quality Improvement Excellent Achievements evaluation. Three projects from Tianjin Chuangyuan Biotechnology Co., Ltd., namely "Improving the Activity of IOB502 Spores," "Separation Technology of Key Antibacterial Components of IOB413," and "Improving the Accuracy of Nattokinase Activity Detection," were recognized as excellent achievements in quality improvement for 2023 in Tianjin.


Focusing on quality improvement to promote quality enhancement. The R&D team at Chuangyuan Biotechnology is based on the internationally advanced segmented solid-state fermentation technology for various probiotics. They focus on scientific verification of intestinal microecology and postbiotics as quality improvement topics, continuously innovating in research, refining processes, enhancing quality, and reducing costs while increasing efficiency. They are committed to achieving tangible improvements in product quality, better providing customers with one-stop product solutions, offering consumers innovative and selected nutritional intervention products, and contributing to public health.

Related News